Inventiva S.A. (LON:0RNK)

Revenue by Product

Financials in millions EUR. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
Oral Small Molecule Therapies	9.20M
Oral Small Molecule Therapies Growth	-47.37%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
China	9.13M
China Growth	98.03%
France	69.00K
France Growth	-41.53%